Amova Asset Management Americas Inc. Reduces Holdings in Corteva, Inc. $CTVA

Amova Asset Management Americas Inc. trimmed its position in shares of Corteva, Inc. (NYSE:CTVA) by 14.0% in the 4th quarter, Holdings Channel reports. The institutional investor owned 292,390 shares of the company’s stock after selling 47,518 shares during the quarter. Amova Asset Management Americas Inc.’s holdings in Corteva were worth $19,599,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. boosted its stake in Corteva by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 80,536,951 shares of the company’s stock worth $5,398,392,000 after buying an additional 317,538 shares during the period. State Street Corp boosted its stake in Corteva by 3.6% during the third quarter. State Street Corp now owns 35,280,805 shares of the company’s stock worth $2,386,041,000 after buying an additional 1,230,074 shares during the period. Franklin Resources Inc. boosted its stake in shares of Corteva by 4.3% during the fourth quarter. Franklin Resources Inc. now owns 19,537,500 shares of the company’s stock valued at $1,309,599,000 after purchasing an additional 805,873 shares during the period. Northern Trust Corp boosted its stake in shares of Corteva by 1.8% during the third quarter. Northern Trust Corp now owns 11,169,284 shares of the company’s stock valued at $755,379,000 after purchasing an additional 194,728 shares during the period. Finally, Norges Bank purchased a new stake in shares of Corteva during the fourth quarter valued at $504,001,000. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Stock Down 1.2%

NYSE:CTVA opened at $74.95 on Wednesday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. The stock has a market capitalization of $50.13 billion, a P/E ratio of 44.09, a P/E/G ratio of 2.32 and a beta of 0.57. The company’s 50-day simple moving average is $80.89 and its 200-day simple moving average is $75.17. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $85.63.

Corteva (NYSE:CTVA) last posted its earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The company had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. During the same quarter in the prior year, the company posted $1.13 earnings per share. Corteva’s revenue for the quarter was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be given a dividend of $0.18 per share. The ex-dividend date of this dividend is Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a yield of 1.0%. Corteva’s dividend payout ratio is presently 42.35%.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on CTVA shares. The Goldman Sachs Group boosted their target price on shares of Corteva from $88.00 to $96.00 and gave the company a “buy” rating in a research note on Tuesday, April 14th. Wells Fargo & Company boosted their target price on shares of Corteva from $85.00 to $90.00 and gave the company an “overweight” rating in a research note on Tuesday, April 21st. Berenberg Bank boosted their target price on shares of Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a research note on Thursday, March 26th. Rothschild & Co Redburn boosted their target price on shares of Corteva from $80.00 to $90.00 and gave the company a “neutral” rating in a research note on Wednesday, April 29th. Finally, Royal Bank Of Canada boosted their target price on shares of Corteva from $95.00 to $97.00 and gave the company an “outperform” rating in a research note on Thursday, May 7th. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $88.48.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.